CytomX Therapeutics, Inc. Employee Count
The employee counts CytomX Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2024-12-31: Employees (as filed) 119; Filing 2025-03-06; Lease expense per employee $60,655.46.
- 2023-12-31: Employees (as filed) 120; Filing 2024-03-11.
- 2022-12-31: Employees (as filed) 116; Filing 2023-03-27.
- 2021-12-31: Employees (as filed) 174; Filing 2022-03-01.
- Available history
- 2018-12-31 to 2024-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2024-12-31 | 119 full-time | 2025-03-06 | $60,655.46 operating + variable |
| 2023-12-31 | 120 full-time | 2024-03-11 | |
| 2022-12-31 | 116 full-time | 2023-03-27 | |
| 2021-12-31 | 174 full-time | 2022-03-01 | |
| 2020-12-31 | 144 full-time | 2021-02-24 | |
| 2019-12-31 | 158 full-time | 2020-02-27 | |
| 2018-12-31 | 137 full-time | 2019-02-27 | $30,656.93 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |